Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19
Detection Principle
review
Target
not specified
Testing Method Category
PCR_KIT
Testing Method
retrospective review on data collected using SARS-CoV-2 qualitative assays using the cobas 6800 / 8800 systems (Roche Molecular Systems), the Abbott m2000 system (Abbott) or a SARS-CoV-2 laboratory-developed test that has received emergency use authorization from the Food and Drug Administration
Testing Method - Additional Info
retrospectively reviewed laboratory-confirmed COVID-19 adult symptomatic cases, eventually achieving cessation of viral RNA shedding (CVS), defined as two consecutive negative SARS-CoV-2 PCR results on nasopharyngeal swabs collected at least 24?h apart
Reported Performance
cumulative CVS rate: 13.5% (2 weeks from symptom onset), 43.8% (3 weeks post symptom onset). Remark: Repeating a SARS-CoV-2 PCR test within 21 days of a laboratory-confirmed COVID-19 diagnosis is considered unnecessary
Sample Size
251 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements